title: Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
authors.forename: H
authors.initials: H
authors.lastname: Zachariae
mesh_terms: D000428:Alcohol Drinking / Q000009:adverse effects; D001152:Arsenicals / Q000009:adverse effects; D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology; D008727:Methotrexate / Q000009:adverse effects*; D010446:Peptide Fragments / Q000032:analysis; D011347:Procollagen / Q000032:analysis; D011565:Psoriasis / Q000188:drug therapy; D014801:Vitamin A / Q000009:adverse effects
chemical_list: D001152:Arsenicals; D015415:Biomarkers; D003879:Dermatologic Agents; D010446:Peptide Fragments; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide; D014801:Vitamin A; D008727:Methotrexate